Advertisement

Reactions Weekly

, Volume 1770, Issue 1, pp 85–85 | Cite as

Bosutinib/dasatinib/nilotinib

Secondary resistance: case report
Case report
  • 20 Downloads

Reference

  1. Dragomir M, et al. The Management of Secondary Resistance CP-CML-Case Report. Clinical Lymphoma, Myeloma & Leukemia 19 (Suppl. 1): S297-S298 abstr. CML-261, Sep 2019. Available from: URL: https://doi.org/10.1016/j.clml.2019.07.250 [abstract] - Romania

Copyright information

© Springer International Publishing AG 2019

Personalised recommendations